Mentor Capital, Inc. (MNTR: OTC Link) | Earnings Exceed Share Price for Low PE Stock of Cancer Funding Mentor


Earnings Exceed Share Price for Low PE Stock of Cancer Funding Mentor

Mar 13, 2012

OTC Disclosure News Service

Ramona, CA –


Weighted average shares outstanding were 2.6 million and 1.9million during  2011 and 2010, respectively.  The current total market capitalization of Mentor Capital is $320,000.


Mentor assets increased to $11.3 million at December 31, 2011, from $1.4 million  at December 31, 2010. Virtually all of the increase came in the last 30 days of the year upon the acquisition of $9.7 Million in cancer company shares and interests.


The company continues free of any recurring debt throughout all of 2010, 2011 and to date.  The portfolio cancer companies will receive $9.7 million in warrant proceeds as those are paid in to Mentor upon exercise by Mentor’s warrant holders.


During the 2011 period, 55% of revenue was from management fees and 45% was from profit on financings or investment. The founder/CEO salary has been unchanged for ten years at $104,000 per year. 


Consolidated comparative financial statements follow below:

About MentorCapital:  Mentor Capital, Inc. is a public company with $125 Million in freely tradable warrants already held by its shareholders.  Mentor pledges the proceeds of those warrants to acquire and invest in leading-edge cancer companies and those medical companies that promote the reduction in cost of delivering cancertreatment.  Detailed and historic company financial reports and additional important relevant information is presented at


Mentor Capital, Inc.                                                                                                        Condensed Consolidated Statements of Operations Data                                                                                          


                                                                               Year ended                  

                                                          Dec. 31, 2011                   Dec. 31, 2010                        

 Revenue                                               $674,642                          $458,000

Operating Expenses                             $238,837                          $280,315

Gain on Investments                             $  80,661                          ($328,790)

Net Income                                            $483,338                           ($143,573)


Fully Diluted Earnings per Share           $0.17/sh                            ($0.07)/sh


Weighted Diluted AverageShares        2,897,284                             1,937.794



Consolidated Balance sheet data                                                  


                                                                        Dec. 31, 2011             Dec. 31,  2010                        


Cash Receivables                                          $  1,463,924               $1,289,048

Total Assets                                                        $11,273,569              $1,417,472

Long-Term Liabilities                                           $10,748,384                 $1,477,363

Stockholders Equity                                             $   467,885                  ($72,669)

Common Shares Outstanding                               2,906,072                  2,188,296    



Forward Looking Statements, Safe Harbor and Risk Descriptions are Incorporated by Reference from the MNTR Company Web Site above.

For further information contact:


Chester Billingsley, CEO                   

Mentor Capital, Inc.

(760) 788 – 4700


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Leave a Reply